These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 16165912)

  • 21. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic factors and results of treating 42 patients with nln-seminomatous germ cell tumor of the testis].
    Czownicki Z; Rogozińska J; Choina B
    Pol Tyg Lek; 1996 Feb; 51(6-9):82-5. PubMed ID: 8756738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure.
    Geldart TR; Gale J; McKendrick J; Kirby J; Mead G
    BJU Int; 2006 Aug; 98(2):353-8. PubMed ID: 16879677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
    BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Stage II testicular seminoma over a period of 40 years.
    Detti B; Livi L; Scoccianti S; Gacci M; Lapini A; Cai T; Meattini I; Mileo AM; Iannalfi A; Bruni A; Biti G
    Urol Oncol; 2009; 27(5):534-8. PubMed ID: 18848787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management of localized germ-cell tumours of the testis].
    Loriot Y; Fizazi K
    Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours.
    Horvath LG; McCaughan BC; Stockle M; Boyer MJ
    Intern Med J; 2002 Mar; 32(3):79-83. PubMed ID: 11885847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
    Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian germ cell tumours: a 17-year study in a single unit.
    Panteli C; Curry J; Kiely E; Pierro A; de Coppi P; Anderson J; Sebire N; Drake D
    Eur J Pediatr Surg; 2009 Apr; 19(2):96-100. PubMed ID: 19360543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management and outcome of bilateral testicular germ cell tumors: Twenty-five year experience in Munich.
    Hentrich M; Weber N; Bergsdorf T; Liedl B; Hartenstein R; Gerl A
    Acta Oncol; 2005; 44(6):529-36. PubMed ID: 16165911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic indications for germinal testicular tumors].
    Bourlaud G; Houlgatte A; Merrer J; Pabot du Chatelard P
    Ann Urol (Paris); 1992; 26(2):119-24. PubMed ID: 1616300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
    Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
    BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Tannir NM; Brown GA; Liu P; Tu SM; Evans JG; Pisters LL
    Urology; 2007 Dec; 70(6):1173-8. PubMed ID: 18158041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
    Wheater MJ; Manners J; Nolan L; Simmonds PD; Hayes MC; Mead GM
    BJU Int; 2011 Dec; 108(11):1794-9. PubMed ID: 21627751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients.
    Ogawa K; Toita T; Nakamura K; Uno T; Onishi H; Itami J; Shikama N; Saeki N; Yoshii Y; Murayama S
    Cancer; 2003 Jul; 98(2):369-76. PubMed ID: 12872359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post orchiectomy management in stage II testicular seminoma.
    Singhal S; Dixit S; Murthy RR; Neema JP; Vyas RK; Baboo HA
    Indian J Cancer; 1994 Dec; 31(4):226-34. PubMed ID: 7533129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
    Malagón HD; Valdez AM; Moran CA; Suster S
    Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of clinical-pathologic variables, staging and prognostic groups, and therapeutic results of 106 germ-cell testicular tumors.
    Bonet AS; Muñoz-Delgado EG; Vico FJ; Ruiz JC; Chapado MS
    Arch Esp Urol; 2011 Dec; 64(10):972-80. PubMed ID: 22228895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical study of testicular cancer].
    Tsumatani K; Ozono S; Momose H; Hirao Y; Okajima E; Kaneko Y; Watanabe S; Samma S; Yamada K
    Hinyokika Kiyo; 1996 Dec; 42(12):943-50. PubMed ID: 9013229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.